MTOR and renal cell carcinoma: Moreover, gypenoside reportedly promoted cell apoptosis via the PI3K/AKT/mTOR signaling pathway in renal cell carcinoma and bladder cancer cells (Liu et al., 2021; Li et al., 2022).